Ida Deichaite, PhD Symposium Organizer, UC San Diego Moores Cancer Center
Ida Deichaite, PhD Symposium Organizer
Director, Industry Relations
UC San Diego Moores Cancer Center
Dr. Ida Deichaite oversees the translational aspects of oncology at MCC, turning innovation into commercial applications. Her work with industry on behalf of MCC conferred competitive advantages to a CIRM Disease Team grant, securing $20 million in funding for an early stage biologic development leading to a clinical trial. This resulted in IND for a first in class biologic drug agent targeting cancer stem cells. Her successful partnering with pharma includes overseeing strategy and execution of translational collaborations between academia and industry, pre-clinical and clinical, in-licensing, and due diligence.
She works closely with the CIRM Alpha Clinic at UC San Diego and the Division of Regenerative Medicine securing industry collaborations. She also organizes the MCC annual “Industry/Academia Translational Oncology Symposium”, which has resulted in numerous collaborations. Previously, Dr. Deichaite was Associate Director of Business Development for Avanir Pharmaceuticals. During her tenure, she established a technology evaluation program for in-licensing compounds. She has co-founded several drug development start-ups.
She is a member of the UCSD Innovation Advisory Board and Section Editor of Science Policy and Industry/Academia Interface of the Journal of Translational Medicine. Dr. Deichaite is widely published in numerous scientific journals. Dr. Deichaite received her Ph.D. from Princeton University, Masters degree from the Weismann Institute, and BA from Hebrew University.
